Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Airway Dysfunction, Occlusions and RemodEling: COPD Patients and Mepolizumab (ADORE)

NCT07749001 is registered in ClinicalTrials.gov with Western University, Canada as lead sponsor.

NCT NCT07749001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07749001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Airway Dysfunction, Occlusions and RemodEling: COPD Patients and Mepolizumab (ADORE)
Lead sponsor
Western University, Canada
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
April 1, 2028
Enrollment
36 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

copd (chronic obstructive pulmonary disease)